Melanotan II has not been established as a sunscreen and should not be used as a substitute for broad-spectrum sunscreen, protective clothing, shade, or avoiding tanning beds
Summary Novo Nordisk will report the topline results from the REDEFINE-1 trial of CagriSema in obese patients before the end of the year
B12 deficiency can affect individuals of all ages and backgrounds, but certain groups are at a higher risk
There is an urgent need for a pharmacological agent that can specifically and safely correct the shared metabolic pathology, ideally by acting at both central (e.g., controlling appetite and cravings) and peripheral (e.g., improving insulin sensitivity, reducing hepatic fat and inflammation) levels to support and enhance existing behavioral strategies, thereby lowering the risk of advanced liver disease development across metabolic and alcoholic etiologies
soft palate first followed by hard palate